6YE-28609-07321
2 vaccinations
9 coded responses
22 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 450 / OH
- Registered
- 2021-03-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-27
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Registered in v-safe
- 2021-03-02
-
2021-03-03
Survey response — days 1–6 daily, dose 1MedDRA: Ageusia — Feeling: Good · Fatigue or tirednessFree text: Some loss of taste that comes and goes since having actual COVIDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
-
2021-03-06
Health check-in — day 7, dose 1Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2021-03-13
Survey response — day 14, dose 1MedDRA: Axillary pain, Heart rate increased, Heart rate irregular, Oedema peripheral — Feeling: GoodFree text: Soreness and lumps in armpit on vaccine armIrregular/fast heart rate like I had when I was positive for COVID 19 back in JanuaryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
-
2021-03-27
Dose 2 — Pfizer-BioNTech
- 2021-03-27
-
2021-03-28
Survey response — days 1–6 daily, dose 2MedDRA: Arthralgia, Chills, Hyperhidrosis, Myalgia — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Overnight chills,sweats, joint and muscle pain. Last 8 hours then felt fineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 2MedDRA: Vision blurred — Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaFree text: Slight blurred visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Ageusia — Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaFree text: Loss of tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Ageusia — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Loss of tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-02
-
2021-04-03
Health check-in — day 7, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
-
2021-06-26
Survey response — 3 months, dose 2MedDRA: Arthralgia, Dyspnoea, Pain — Feeling: GoodFree text: Random shooting pain in some joints including fingersSome breathing issues under physical stressMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-09-27
Survey response — 6 months, dose 2MedDRA: Arthralgia, Condition aggravated, Headache, Pain, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activitiesFree text: Shooting pain in random joints continues to happen.Random intense headaches. Increased level of food sensitivities and environmental allergies.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-27
Survey response — 12 months, dose 2MedDRA: Injected limb mobility decreased, Injection site pain, Neuralgia, Office visit, Physiotherapy, Rotator cuff syndrome — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Just after my booster I began having pain in the injected arm near the site of injection. Pain escalated over a couple of months. Surgeon stated impinged shoulder. Nerve pain going down arm. Now in physical therapy 2x/week to regain mobility. · Healthcare visit (other): Surgeon review of symptoms/ X-rayMedDRA releases: 2024-11 · check-in free text available
-
2022-03-27
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-27 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Some loss of taste that comes and goes since having actual COVID
Release 5 — day 14, dose 1
Symptoms: Soreness and lumps in armpit on vaccine armIrregular/fast heart rate like I had when I was positive for COVID 19 back in January
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Overnight chills,sweats, joint and muscle pain. Last 8 hours then felt fine
Systemic reaction (other): Slight blurred vision
Systemic reaction (other): Loss of taste
Systemic reaction (other): Loss of taste
Release 9 — 3 months, dose 2
Symptoms: Random shooting pain in some joints including fingersSome breathing issues under physical stress
Release 9 — 6 months, dose 2
Symptoms: Shooting pain in random joints continues to happen.Random intense headaches. Increased level of food sensitivities and environmental allergies.
Release 11 — 12 months, dose 2
Symptoms: Just after my booster I began having pain in the injected arm near the site of injection. Pain escalated over a couple of months. Surgeon stated impinged shoulder. Nerve pain going down arm. Now in physical therapy 2x/week to regain mobility.
Healthcare visit (other): Surgeon review of symptoms/ X-ray
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Axillary pain | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Heart rate irregular | ✓ | ✓ | ✓ |
| SD | Injected limb mobility decreased | · | · | ✓ |
| SD | Injection site pain | · | · | ✓ |
| SD | Neuralgia | · | · | ✓ |
| SD | Oedema peripheral | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Physiotherapy | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rotator cuff syndrome | · | · | ✓ |
| SRO | Ageusia | ✓ | ✓ | ✓ |
| SRO | Arthralgia | ✓ | ✓ | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release